These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
27. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis. Öztürk AA; Namlı İ; Güleç K; Kıyan HT Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668 [TBL] [Abstract][Full Text] [Related]
28. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management. Girotra P; Singh SK AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007 [TBL] [Abstract][Full Text] [Related]
29. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. Arias JL; López-Viota M; López-Viota J; Delgado AV Int J Pharm; 2009 Dec; 382(1-2):270-6. PubMed ID: 19712736 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies. Alsarra IA Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815 [TBL] [Abstract][Full Text] [Related]
31. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Attama AA; Reichl S; Müller-Goymann CC Int J Pharm; 2008 May; 355(1-2):307-13. PubMed ID: 18242022 [TBL] [Abstract][Full Text] [Related]
32. A novel Diclofenac-carrier for local treatment of osteoarthritis applying live-animal MRI. Elron-Gross I; Glucksam Y; Biton IE; Margalit R J Control Release; 2009 Apr; 135(1):65-70. PubMed ID: 19146892 [TBL] [Abstract][Full Text] [Related]
33. Araucaria Gum: Novel Natural Polymer for Controlled Drug Delivery. Development, In Vitro and In Vivo Evaluation of Araucaria Gum Based Matrix Tablets for Controlled Release. Naga Durga DH; Lohithasu D; Ramana Murthy Kolapalli V Curr Drug Deliv; 2017; 14(7):955-967. PubMed ID: 28034362 [TBL] [Abstract][Full Text] [Related]
34. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation. Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299 [TBL] [Abstract][Full Text] [Related]
35. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Fujisawa T; Miyai H; Hironaka K; Tsukamoto T; Tahara K; Tozuka Y; Ito M; Takeuchi H Int J Pharm; 2012 Oct; 436(1-2):564-7. PubMed ID: 22828072 [TBL] [Abstract][Full Text] [Related]
36. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Jain S; Patel N; Madan P; Lin S Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793 [TBL] [Abstract][Full Text] [Related]
37. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain. Salunkhe SS; Bhatia NM; Bhatia MS Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227 [TBL] [Abstract][Full Text] [Related]
38. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam. Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289 [TBL] [Abstract][Full Text] [Related]
39. Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids. Chinaeke EE; Chime SA; Onyishi VI; Attama AA; Okore VC Drug Deliv; 2015; 22(5):652-65. PubMed ID: 24479677 [TBL] [Abstract][Full Text] [Related]
40. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]